Receipts Drop 58% to $0.211M as Uscom Sells Subsidiaries for $2.59M
Uscom Limited has sold its entire business for $2.59 million, leaving the company with negligible cash and suspended trading status as it seeks new acquisition opportunities.
- Receipts from customers fell to AUD 0.211 million
- Operating cash outflow improved to AUD 0.397 million
- Sale of all subsidiaries completed for AUD 2.59 million
- Company remains listed but suspended from ASX trading
- Cash at quarter end stood at AUD 706,967
Quarterly Cash Flow Highlights
Uscom Limited (ASX:UCM) reported a sharp decline in receipts from customers to AUD 211,000 for the quarter ending 31 December 2025, down from AUD 505,000 in the previous quarter. Despite this, the operating cash outflow improved to AUD 397,000, a significant reduction from AUD 894,000 previously, reflecting lower product manufacturing and operating costs which dropped to AUD 105,000 from AUD 330,000.
However, administration and corporate expenses rose to AUD 713,000, up from AUD 939,000 in the prior corresponding period, with director fees accounting for AUD 13,000 of this figure. The company ended the quarter with a cash balance of AUD 706,967.
Business Sale and Trading Suspension
In a major strategic move, Uscom completed the sale of all its subsidiaries, including its wholly owned subsidiary Uscom SNG Pte. Ltd, to Singapore-based AXO Medtech VCC for AUD 2.591 million. This transaction was approved by shareholders at the annual general meeting held on 7 November 2025 and completed on 20 November 2025.
The consideration for the sale was settled by transferring liabilities amounting to AUD 1.591 million owed to Professor Phillips, the Chairman of Uscom, and AUD 1.0 million owed to Jetan Pty Limited, a substantial shareholder. With the disposal of its main business operations, Uscom ceased trading activities and is currently suspended from trading on the ASX, though it remains a listed entity.
Future Prospects and Financial Position
Following the sale, Uscom has no operating activities and reported no expectation of continuing operating cash flows. The company confirmed it does not anticipate raising further funds at this stage and has no current financing facilities available. Uscom's management is actively seeking a suitable acquisition to align with its commercial goals and shareholder expectations, signaling a potential new chapter for the company.
The company’s cash position, while modest at just over AUD 700,000, reflects the winding down of operations and the financial effects of the business sale. The company’s ability to meet future business objectives will depend on securing new business opportunities or capital injections.
Bottom Line?
Uscom’s transition post-sale leaves it with limited cash and no active operations, making the search for a new acquisition critical to its future viability.
Questions in the middle?
- What types of acquisitions is Uscom targeting to revive operations?
- How will the disposal of liabilities to related parties affect future financial flexibility?
- What timeline can shareholders expect for Uscom to resume trading on the ASX?
